Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selegiline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN119390634A enables high-purity impurity synthesis ensuring supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN1197447A discloses a robust method for resolving racemates like selegiline and ephedrine using stable phenoxypropionic acid derivatives, offering high purity and scalable manufacturing advantages.